{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:12:30Z","timestamp":1788541950505,"version":"build-2803163510"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,4]]},"DOI":"10.7759\/cureus.115782","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:16:44Z","timestamp":1788538604000},"source":"Crossref","is-referenced-by-count":0,"title":["Macular Telangiectasia Type 2: A Case Series"],"prefix":"10.7759","author":[{"given":"Vinith R","family":"Devarakonda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurunadh S","family":"Velamakanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padala V","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kandula","family":"Satish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gattineni","family":"Dharani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S373538","article-title":"Macular telangiectasia type 2: a comprehensive review","volume":"16","author":"Kedarisetti KC","year":"2022","unstructured":"Kedarisetti KC, Narayanan R, Stewart MW, Reddy Gurram N, Khanani AM. Macular telangiectasia type 2: a comprehensive review. Clin Ophthalmol. 2022, 16:3297-309. 10.2147\/OPTH.S373538","journal-title":"Clin Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2012.11.002","article-title":"Macular telangiectasia type 2","volume":"34","author":"Charbel Issa P","year":"2013","unstructured":"Charbel Issa P, Gillies MC, Chew EY, et al.. Macular telangiectasia type 2. Prog Retin Eye Res. 2013, 34:49-77. 10.1016\/j.preteyeres.2012.11.002","journal-title":"Prog Retin Eye Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-10580","article-title":"\"En face\" OCT imaging of the IS\/OS junction line in type 2 idiopathic macular telangiectasia","volume":"53","author":"Sallo FB","year":"2012","unstructured":"Sallo FB, Peto T, Egan C, et al.. \"En face\" OCT imaging of the IS\/OS junction line in type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci. 2012, 53:6145-52. 10.1167\/iovs.12-10580","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/01.iae.0000256663.94734.e1","article-title":"Optical coherence tomography findings in nonproliferative group 2a idiopathic juxtafoveal retinal telangiectasis","volume":"27","author":"Cohen SM","year":"2007","unstructured":"Cohen SM, Cohen ML, El-Jabali F, Pautler SE. Optical coherence tomography findings in nonproliferative group 2a idiopathic juxtafoveal retinal telangiectasis. Retina. 2007, 27:59-66. 10.1097\/01.iae.0000256663.94734.e1","journal-title":"Retina"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3109\/09286580903450361","article-title":"Baseline characteristics of participants in the natural history study of macular telangiectasia (MacTel) MacTel Project Report No. 2","volume":"17","author":"Clemons TE","year":"2010","unstructured":"Clemons TE, Gillies MC, Chew EY, Bird AC, Peto T, Figueroa MJ, Harrington MW. Baseline characteristics of participants in the natural history study of macular telangiectasia (MacTel) MacTel Project Report No. 2. Ophthalmic Epidemiol. 2010, 17:66-73. 10.3109\/09286580903450361","journal-title":"Ophthalmic Epidemiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-021-00361-3","article-title":"Serine biosynthesis defect due to haploinsufficiency of PHGDH causes retinal disease","volume":"3","author":"Eade K","year":"2021","unstructured":"Eade K, Gantner ML, Hostyk JA, et al.. Serine biosynthesis defect due to haploinsufficiency of PHGDH causes retinal disease. Nat Metab. 2021, 3:366-77. 10.1038\/s42255-021-00361-3","journal-title":"Nat Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200509000-00007","article-title":"Long-term juxtafoveal retinal telangiectasia","volume":"25","author":"Watzke RC","year":"2005","unstructured":"Watzke RC, Klein ML, Folk JC, Farmer SG, Munsen RS, Champfer RJ, Sletten KR. Long-term juxtafoveal retinal telangiectasia. Retina. 2005, 25:727-35. 10.1097\/00006982-200509000-00007","journal-title":"Retina"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2006.05.003","article-title":"M\u00fcller cells in the healthy and diseased retina","volume":"25","author":"Bringmann A","year":"2006","unstructured":"Bringmann A, Pannicke T, Grosche J, et al.. M\u00fcller cells in the healthy and diseased retina. Prog Retin Eye Res. 2006, 25:397-424. 10.1016\/j.preteyeres.2006.05.003","journal-title":"Prog Retin Eye Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-021-00848-4","article-title":"Genetic disruption of serine biosynthesis is a key driver of macular telangiectasia type 2 aetiology and progression","volume":"13","author":"Bonelli R","year":"2021","unstructured":"Bonelli R, Ansell BR, Lotta L, et al.. Genetic disruption of serine biosynthesis is a key driver of macular telangiectasia type 2 aetiology and progression. Genome Med. 2021, 13:39. 10.1186\/s13073-021-00848-4","journal-title":"Genome Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3799","article-title":"Genome-wide analyses identify common variants associated with macular telangiectasia type 2","volume":"49","author":"Scerri TS","year":"2017","unstructured":"Scerri TS, Quaglieri A, Cai C, et al.. Genome-wide analyses identify common variants associated with macular telangiectasia type 2. Nat Genet. 2017, 49:559-67. 10.1038\/ng.3799","journal-title":"Nat Genet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/529912-macular-telangiectasia-type-2-a-case-series","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:16:45Z","timestamp":1788538605000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/529912-macular-telangiectasia-type-2-a-case-series"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.115782","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,4]]}}}